Founded in
2017
Description
SHORT DESCRIPTION:
DIOSynVax customises vaccine antigen design to maximise the protection that vaccines can provide worldwide against existing and future viruses. Grounded firmly in virus structure and evolution, our method is patent protected, combining computational biology with in vitro and in vivo validation, selecting the best Vaccine Antigen Payload (VAP) candidates while growing a reservoir of data that continually improves our designs.
LONG DESCRIPTION:
Based in
Cambridge, Cambridgeshire
Nation
Founding Status
$ 2.5 Millions - $ 5 Millions
Add a review